Revolutionizing Pharmaceutical Isotope Production for the Future
Nu Planet is a cutting-edge startup that is transforming the industry of pharmaceutical isotope production. With a new scalable production process for rare isotopes, Nu Planet has set its sights on revolutionizing the pharma, energy, space, and defense sectors.
Disrupting a Multi-Billion Dollar Market
Nu Planet has identified a clear opportunity to disrupt the market by creating a new, more efficient process for isotope production. The current US supply is dominated by the National Isotope Development Center (NIDC), which limits competition and limits innovation. Nu Planet’s multi-isotope platform, led by nuclear physics expert Dr. Steve Howe, is creating a new benchmark for cost and quality, paving the way for other business to follow.
Game-Changing Rare Isotopes
Nu Planet’s focus is on two priority isotopes, Actinium-225 and Lead-212, which have been identified as essential for small-scale medical use, but are currently in short supply due to their high production costs. Nu Planet’s scalable process will drastically reduce the cost of production, making them more readily available and affordable for medical professionals and researchers.
Scaling from Lab to Commercial Production
Nu Planet’s roadmap to commercial success is clear, with the company scaling from the lab to commercial production in Scottsdale, Arizona by 2022. By meeting the high demand for Actinium-225 and Lead-212, Nu Planet aims to become a major player in the pharmaceutical and nuclear industries, driving innovation and pushing the boundaries of our understanding of nuclear physics.
Intrigued by Nu Planet’s innovation? Then head to their website to find out more and learn about their groundbreaking work. You can follow them on Twitter and LinkedIn to stay up-to-date with their latest news and achievements. The future of isotope production is here, and it’s being led by Nu Planet.
Website: http://nuplanet.tech
Twitter: @NuPlanetradio
LinkedIn: https://www.linkedin.com/company/30595043
Ready to amplify your reach and engage with the most dynamic community in the venture world? Consider sponsoring an article with us. Learn more about our promotional opportunities and sponsored articles here.
Your story could be the next big hit on US Venture News!
Follow Us